Zhejiang Jingxin Pharmaceutical Co Ltd (002020) — Cash Flow Reinvestment Rate
Zhejiang Jingxin Pharmaceutical Co Ltd (002020) has a Cash Flow Reinvestment Rate of 0.16x as of September 2025, reinvesting CN¥35.55 Million (capex CN¥35.55 Million ) from operating cash flow of CN¥227.64 Million. See 002020 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Zhejiang Jingxin Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2002–2025)
Historical reinvestment intensity for Zhejiang Jingxin Pharmaceutical Co Ltd across 22 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Zhejiang Jingxin Pharmaceutical Co Ltd.
Annual Cash Flow Reinvestment Rate for Zhejiang Jingxin Pharmaceutical Co Ltd (2002–2025)
Year-by-year capital reinvestment analysis for Zhejiang Jingxin Pharmaceutical Co Ltd. See financial flexibility index of Zhejiang Jingxin Pharmaceutical Co Ltd to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.98x | CN¥768.92 Million | CN¥781.35 Million | CN¥202.85 Million | ▼ -50.0% |
| 2024 | 1.97x | CN¥1.43 Billion | CN¥726.16 Million | CN¥250.65 Million | ▲ +29.1% |
| 2023 | 1.52x | CN¥1.26 Billion | CN¥824.69 Million | CN¥519.51 Million | ▲ +52.0% |
| 2022 | 1.00x | CN¥857.97 Million | CN¥855.78 Million | CN¥515.57 Million | ▼ -59.9% |
| 2021 | 2.50x | CN¥912.77 Million | CN¥365.02 Million | CN¥404.43 Million | ▲ +23.2% |
| 2020 | 2.03x | CN¥1.04 Billion | CN¥513.21 Million | CN¥334.00 Million | ▲ +196.3% |
| 2019 | 0.68x | CN¥366.65 Million | CN¥535.30 Million | CN¥337.33 Million | ▲ +45.5% |
| 2018 | 0.47x | CN¥246.39 Million | CN¥523.40 Million | CN¥242.19 Million | ▼ -86.4% |
| 2017 | 3.45x | CN¥1.33 Billion | CN¥385.01 Million | CN¥112.19 Million | ▲ +68.1% |
| 2016 | 2.05x | CN¥519.01 Million | CN¥252.69 Million | CN¥95.26 Million | ▲ +96.8% |
| 2015 | 1.04x | CN¥151.04 Million | CN¥144.69 Million | CN¥114.31 Million | ▲ +131.9% |
| 2014 | 0.45x | CN¥94.75 Million | CN¥210.49 Million | CN¥94.75 Million | ▼ -53.8% |
| 2013 | 0.98x | CN¥108.28 Million | CN¥111.03 Million | CN¥108.28 Million | ▼ -29.6% |
| 2012 | 1.39x | CN¥83.51 Million | CN¥60.28 Million | CN¥83.51 Million | ▲ +33.8% |
| 2011 | 1.04x | CN¥71.86 Million | CN¥69.41 Million | CN¥71.86 Million | ▼ -60.4% |
| 2010 | 2.62x | CN¥155.87 Million | CN¥59.55 Million | CN¥155.87 Million | ▲ +1655.7% |
| 2009 | 0.15x | CN¥20.18 Million | CN¥135.38 Million | CN¥20.18 Million | ▼ -89.8% |
| 2008 | 1.46x | CN¥43.81 Million | CN¥29.98 Million | CN¥43.81 Million | ▼ -32.9% |
| 2005 | 2.18x | CN¥134.67 Million | CN¥61.82 Million | CN¥134.67 Million | ▼ -85.7% |
| 2004 | 15.26x | CN¥98.11 Million | CN¥6.43 Million | CN¥98.11 Million | ▲ +889.6% |
| 2003 | 1.54x | CN¥71.19 Million | CN¥46.18 Million | CN¥71.19 Million | ▲ +46.8% |
| 2002 | 1.05x | CN¥47.79 Million | CN¥45.50 Million | CN¥47.79 Million | — |